Marcellones, Mark .
HRN: 22-18-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/31/2023
01/07/2024
IVT
4ml
TID
Amoebiasis
Waiting Final Action
Indication: Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes